Photocure ASA - Presentation of a new commercial strategy for Hexvix®

Published: 27 September 2011Medical congresses & events

Photocure, the Norwegian specialty pharmaceutical company focused in dermatology and cancer, is pleased to invite to a presentation on Tuesday 27 September 2011 to further execution of a new commercial strategy for Hexvix in partnership with Ipsen, a global specialty-driven biopharmaceutical company.

Please find the full presentation enclosed.  

The presentation is held at Hotel Continental, Stortingsgaten 24/26, Oslo.
The presentation starts at 11:00.

For more information, please contact:
Christian Fekete
Photocure ASA

Tel: + 47 916 42 938, E-mail:

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

News and events